Anxiety and mood (대한불안의학회지)

Korean Academy of Anxiety Disorders (대한불안의학회)
권호 표지

Factors Associated with Overweight and Obesity in Inpatients with Bipolar Mania : A Preliminary Study

양극성 조증 입원 환자에서 과체중, 비만과 연관 인자 : 예비 연구

  • Jung, Young-Eun (Department of Psychiatry, College of Medicine The Catholic University of Korea) ;
  • Seo, Ho-Jun (Department of Psychiatry, College of Medicine The Catholic University of Korea) ;
  • Song, Hoo-Rim (Department of Psychiatry, College of Medicine The Catholic University of Korea) ;
  • Wang, Hee-Ryung (Department of Psychiatry, College of Medicine The Catholic University of Korea) ;
  • Jun, Tae-Youn (Department of Psychiatry, College of Medicine The Catholic University of Korea) ;
  • Bahk, Won-Myong (Department of Psychiatry, College of Medicine The Catholic University of Korea)
  • 정영은 (가톨릭대학교 의과대학 정신과학교실) ;
  • 서호준 (가톨릭대학교 의과대학 정신과학교실) ;
  • 송후림 (가톨릭대학교 의과대학 정신과학교실) ;
  • 왕희령 (가톨릭대학교 의과대학 정신과학교실) ;
  • 전태연 (가톨릭대학교 의과대학 정신과학교실) ;
  • 박원명 (가톨릭대학교 의과대학 정신과학교실)
  • Received : 2010.09.03
  • Accepted : 2010.10.11
  • Published : 2010.10.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objective : Being overweight or obesity impairs quality of life and often causes treatment noncompliance in patients with bipolar disorder. This preliminary study evaluated the prevalence of overweight and obesity in inpatients with bipolar mania. Methods : Inpatients with bipolar mania, who were treated with adequate medications at least 4 weeks were included in a retrospective study. The body weight of each patient was measured and the body mass index (BMI) was calculated. Results : Of the 80 patients, 16.4% (N=13) were overweight, and 35.0% (N=28) were obese at discharge. Female patients had higher prevalence rates of overweight and obesity. Being overweight or obesity was associated with the number of previous episodes of depression and combination treatment with atypical antipsychotics and mood stabilizers. Conclusions : Being overweight or obesity is highly prevalent in patients with bipolar mania. Clinicians should pay more attention to weight gain and obesity when prescribing combination therapies. More research is required to identify the impact of specific risk factors for overweight and obesity in patients with bipolar mania.

Keywords

References

  1. Haslam DW, James WP. Obesity. Lancet 2005;366:1197-1209. https://doi.org/10.1016/S0140-6736(05)67483-1
  2. James PT, Leach R, Kalamara E, Shayeghi M. The Worldwide Obesity. Epidemic Obes Res 2001;9:228-233. https://doi.org/10.1038/oby.2001.123
  3. Behn A, Ur E. The obesity epidemic and its cardiovascular consequences. Curr Opin Cardiol 2006;21:353-360. https://doi.org/10.1097/01.hco.0000231406.84554.96
  4. Rosenbaum M, Leibel RL, Hirsch J. Medical progress: obesity. N Engl J Med 1997;337:396-407. https://doi.org/10.1056/NEJM199708073370606
  5. Kurzthaler I, Fleischhacker WW. The clinical implications of weight gain in schizophrenia. J Clin Psychiatry 2001;62(suppl 7):32-37.
  6. Keck PE, McElroy SL. Bipolar disorder, obesity, and pharmacotherapy- associated weight gain. J Clin Psychiatry 2003;64:1426-1435. https://doi.org/10.4088/JCP.v64n1205
  7. Malhotra S, McElroy SL. Associations between metabolic syndrome and psychiatric disorder. Prim Psychiatry 2003;10:37-44.
  8. Fagiolini A, Frank E, Houck PR, Mallinger A, Swartz H, Buysse DJ, et al. Prevalence of obesity and weight change during treatment in patients with bipolar I disorder. J Clin Psychiatry 2002;63:528-534. https://doi.org/10.4088/JCP.v63n0611
  9. Elmslie JL, Mann JI, Silverstone JT, Williams SM, Romans SE. Determinants of overweight and obesity in patients with bipolar disorder. J Clin Psychiatry 2001;62:486-491. https://doi.org/10.4088/JCP.v62n0614
  10. Ramacciotti CE, Paoli RA, Marcacci G, Piccinni A, Burgalassi A, Dell'Osso L, et al. Relationship between bipolar illness and bingeeating disorders. Psychiatry Res 2005;135:165-170. https://doi.org/10.1016/j.psychres.2004.04.014
  11. Kruger S, Shugar G, Cooke RG. Comorbidity of binge eating disorder and the partial binge eating syndrome with bipolar disorder. Int J Eat Disord 1996;19:45-52. https://doi.org/10.1002/(SICI)1098-108X(199601)19:1<45::AID-EAT6>3.0.CO;2-W
  12. Vornik LA, Brown ES. Management of comorbid bipolar disorder and substance abuse. J Clin Psychiatry 2006;67(Suppl 7):24-30.
  13. Grant BF, Hasin DS, Chou SP, Stinson FS, Dawson DA. Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry 2004;61:1107-1115. https://doi.org/10.1001/archpsyc.61.11.1107
  14. Taylor V, Macqueen G. Associations between bipolar disorder and metabolic syndrome: a review. J Clin Psychiatry 2006;67:1034-1041. https://doi.org/10.4088/JCP.v67n0704
  15. Fava M. Weight gain and antidepressants. J Clin Psychiatry 2000;61 (suppl 11):37-41.
  16. Wirshing DA, Wirshing WC, Kysar L, Berisford MA, Goldstein D, Pashdag J, et al. Novel antipsychotics: comparison of weight gain liabilities. J Clin Psychiatry 1999;60:358-363. https://doi.org/10.4088/JCP.v60n0602
  17. Nemeroff CB. Safety of available agents used to treat bipolar disorder: focus on weight gain. J Clin Psychiatry 2003;64:532-539. https://doi.org/10.4088/JCP.v64n0506
  18. American Psychiatry Association. Diagnostic and Statistical Manual of Mental Disorder 4th ed. Washington DC, American Psychiatric Press; 1994.
  19. Kanazawa M, Yoshiike N, Osaka T, Numba Y, Zimmet P, Inoue S. Criteria and classification of obesity in Japan and Asia-Oceania. World Rev Nutr Diet 2005;94:1-12.
  20. Kim DM, Ahn CW, Nam SY. Prevalence of obesity in Korea. Obes Rev 2005;6:117-121. https://doi.org/10.1111/j.1467-789X.2005.00173.x
  21. Elmslie JL, Silverstone JT, Mann JI, Williams SM, Romans SE. Prevalence of over weight and obesity in bipolar patients. J Clin Psychiatry 2000;61:179-184. https://doi.org/10.4088/JCP.v61n0306
  22. McElroy SL, Frye MA, Suppes T, Dhavale D, Keck PE Jr, Leverich GS, et al. Correlates of overweight and obesity in 644 patients with bipolar disorder. J Clin Psychiatry 2002;63:207-213. https://doi.org/10.4088/JCP.v63n0306
  23. Kim B, Kim SJ, Son JI, Joo YH. Weight change in the acute treatment of bipolar I disorder: a naturalistic observational study of psychiatric inpatients. J Affect Disord 2008;105:45-52. https://doi.org/10.1016/j.jad.2007.04.006
  24. Shi H, Clegg DJ. Sex differences in the regulation of body weight. Physiol Behav 2009;97:199-204. https://doi.org/10.1016/j.physbeh.2009.02.017
  25. Phillips GB, Jing T, Heymsfield SB. Does insulin resistance, visceral adiposity, or a sex hormone alteration underlie the metabolic syndrome? Studies in women. Metabolism 2008;57:838-844. https://doi.org/10.1016/j.metabol.2008.01.029
  26. Stedman T, Welham J. The distribution of adipose tissue in female patients receiving psychotropic drugs. Br J Psychiatry 1993;162:249-250. https://doi.org/10.1192/bjp.162.2.249
  27. Silverstone T, Smith G, Goodall E. Prevalence of obesity in patients receiving depot antipsychotics. Br J Psychiatry 1988;153:214-217. https://doi.org/10.1192/bjp.153.2.214
  28. Allison DB, Fontaine KR, Heo M, Mentore JL, Cappelleri JC, Chandler LP, et al. The distribution of body mass index among individuals with and without schizophrenia. J Clin Psychiatry 1999;60:215-220. https://doi.org/10.4088/JCP.v60n0402
  29. Vestergaard P, Poulstrup M, Schou M. Prospective studies in a lithium cohort, 3: tremor, weight gain, diarrhea, psychological complaints. Acta Psychiatr Scand 1988;78:434-441. https://doi.org/10.1111/j.1600-0447.1988.tb06363.x
  30. Bowden CL, Calabrese JR, McElroy SL, Gyulai L, Wassef A, Petty F, et al. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. Arch Gen Psychiatry 2000;57:481-489. https://doi.org/10.1001/archpsyc.57.5.481
  31. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 2004;27:596-601. https://doi.org/10.2337/diacare.27.2.596
  32. Marken PA, Pies RW. Emerging treatments for bipolar disorder: safety and adverse effect profiles. Ann Pharmacother 2006;40:276-285. https://doi.org/10.1345/aph.1G112
  33. Reynolds GP, Zhang ZJ, Zhang XB. Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism. Lancet 2002;359:2086-2087. https://doi.org/10.1016/S0140-6736(02)08913-4
  34. Tohen M, Greil W, Calabrese JR, Sachs GS, Yatham LN, Oerlinghausen BM, et al. Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial. Am J Psychiatry 2005;162:1281-1290. https://doi.org/10.1176/appi.ajp.162.7.1281
  35. Tohen M, Ketter TA, Zarate CA, Suppes T, Frye M, Altshuler L, et al. Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study. Am J Psychiatry 2003; 160:1263-1271. https://doi.org/10.1176/appi.ajp.160.7.1263